Summary: Tune into the Cultivate Wellness Podcast to listen to a recent interview with Brad Burge of MAPS as he discusses psychedelic-assisted psychotherapy, the history of MDMA, the protocol for Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD, and the upcoming Psychedelic Science Summit in Austin, TX, November 1-3.
Originally appearing here.
Brad Burge, Director of Strategic Communications of MAPS.org, joins me to discuss the important work that MAPS is doing to study possible medicinal qualities of psychedelic drugs (MDMA, mushrooms, LSD, etc). Check out their Psychedelic Science Summit in Austin, TX, November 1st – 3rd!
